Overview

• Teddi Mellencamp's stage 4 metastatic melanoma in her brain and lungs is responding well to immunotherapy, with tumors shrinking or disappearing.
• Doctors have outlined a two-year treatment plan for Mellencamp, requiring immunotherapy every four weeks and scans every three months for monitoring.
• Immunotherapy is both reducing existing tumors and aiming to prevent recurrence, offering hope for long-term remission or potential cure.
• Mellencamp has shared her journey publicly to promote awareness of melanoma and the importance of early detection through regular skin checks.
• While not yet cancer-free, Mellencamp's doctors are optimistic about her recovery if her treatment continues to progress as expected.